Inventor · disambiguated record
Barbara Enenkel
Also filed as: ENENKEL BARBARA
20 granted patents·13 pending applications·155 citations·filing 1996–2023
93Inventor score
Files withENENKEL BARBARA11BOEHRINGER INGELHEIM PHARMA10BOEHRINGER INGELHEIM INT3ALTRUBIO INC2FLORIN LORE2
Top patents by PatentIndex Score
33 records- 0190US8338179B2Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene productENENKEL BARBARA·Filed 2008·Granted Dec 25, 2012·15 cites·31 claims
- 0285US6063598AStrong homologous promoter obtained from hamstersTHOMAE GMBH DR K·Filed 1996·Granted May 16, 2000·90 cites·39 claims
- 0384US7384744B2Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such productsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jun 10, 2008·16 cites·11 claims
- 0484US7344886B2Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene productBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Mar 18, 2008·11 cites·10 claims
- 0583US11897964B2Anti-PSGL-1 antibodies and uses thereofALTRUBIO INC·Filed 2021·Granted Feb 13, 2024·1 cites·5 claims
- 0682US7732181B2Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene productBOEHRINGER INGELHEIM PHARMA·Filed 2008·Granted Jun 8, 2010·7 cites·31 claims
- 0780US8975391B2Regulatory elementsENENKEL BARBARA·Filed 2013·Granted Mar 10, 2015·2 cites·11 claims
- 0879US9493803B2Artificial intronsENENKEL BARBARA·Filed 2013·Granted Nov 15, 2016·2 cites·20 claims
- 0979US9249201B2Heterologous intron within a signal peptideENENKEL BARBARA·Filed 2013·Granted Feb 2, 2016·2 cites·19 claims
- 1079US9243053B2Heterologous intron within an immunoglobulin domainENENKEL BARBARA·Filed 2013·Granted Jan 26, 2016·2 cites·22 claims
- 1179US8466271B2Regulatory elementsENENKEL BARBARA·Filed 2009·Granted Jun 18, 2013·2 cites·26 claims
- 1277US2024124604A1Anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2023·Application pending·0 cites
- 1374US9708636B2Artificial intronsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Jul 18, 2017·1 cites·7 claims
- 1470US7833787B2Method for recloning Chinese hamster ovary (CHO) cellsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Nov 16, 2010·2 cites·10 claims
- 1568US7968341B2Sequence specific DNA recombination in eukaryotic cellsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jun 28, 2011·2 cites·14 claims
- 1661US8404486B2Recombination sequencesENENKEL BARBARA·Filed 2008·Granted Mar 26, 2013·0 cites·24 claims
- 1756US2008124760A1Regulatory Nucleic Acid ElementsENENKEL BARBARA·Filed 2007·Application pending·0 cites
- 1854US2013251708A1Anti-psgl-1 antibodies and uses thereofABGENOMICS COOPERATIEF UA·Filed 2013·Application pending·0 cites
- 1954US2009162900A1Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such of such productsENENKEL BARBARA·Filed 2008·Application pending·0 cites
- 2053US7491539B2Sequence specific DNA recombination in eukaryotic cellsBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Feb 17, 2009·0 cites·22 claims
- 2151US7846732B2Sequence specific DNA recombination in eukaryotic cellsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Dec 7, 2010·0 cites·21 claims
- 2250US9045776B2Regulatory nucleic acid elementsENENKEL BARBARA·Filed 2010·Granted Jun 2, 2015·0 cites·19 claims
- 2350US2013209449A9Anti-psgl-1 antibodies and uses thereofBASSARAB STEFAN·Filed 2012·Application pending·0 cites
- 2448US2014248665A1Novel intron sequencesENENKEL BARBARA·Filed 2013·Application pending·0 cites
- 2548US2003219871A1Host cells having improved cell survival properties and methods to generate such cellsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 2647US2013210074A1Epigenetic engineeringFLORIN LORE·Filed 2013·Application pending·0 cites
- 2747US2010297697A1Methods for increasing protein titersBOEHRINGER INGELHEIM PHARMA·Filed 2008·Application pending·0 cites
- 2847US2011201785A1Method for optimizing proteins having the folding pattern of immunoglobulinBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 2945US2011281301A1The secretory capacity in host cellsKAUFMANN HITTO·Filed 2008·Application pending·0 cites
- 3045US2011124108A1Epigenetic engineeringBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3142US9708626B2Regulatory nucleic acid elementsBOEHRINGER INGELHEIM PHARMA·Filed 2015·Granted Jul 18, 2017·0 cites·8 claims
- 3234US8669109B2Methods of producing proteins in Chinese hamster ovary (CHO) cellsOTTO RALF·Filed 2010·Granted Mar 11, 2014·0 cites·21 claims
- 3332US2012190065A1Combinatorial engineeringFLORIN LORE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Barbara Enenkel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →